Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Brain Neoplasms 293Glioblastoma 263Glioma 208Neuroblastoma 88Neoplasms 62Astrocytoma 57Central Nervous System Neoplasms 54Medulloblastoma 48Breast Neoplasms 44Melanoma 41Sarcoma 40Neurofibromatosis 1 39Meningioma 39Carcinoma, Non-Small-Cell Lung 39Lung Neoplasms 37Ependymoma 37Osteosarcoma 32Rhabdomyosarcoma 31Sarcoma, Ewing 28Neoplasm Metastasis 28Diffuse Intrinsic Pontine Glioma 28Rhabdoid Tumor 27Recurrence 26Oligodendroglioma 24Gliosarcoma 22Wilms Tumor 21Pancreatic Neoplasms 21Pheochromocytoma 20Hepatoblastoma 20Neurofibroma, Plexiform 19

Interventions

enasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × CNS × 90 days × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2026-05-20

RABBIT

University of Arizona

Phase 1/2 Recruiting
30 enrolled
CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡